(NRC) National Research Corporation ANSOFF Analysis Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(NRC) National Research Corporation Complete Analysis Pack
Make Smarter Expansion Decisions with the Full Report
This National Research Corporation Ansoff Matrix Analysis maps growth options across market penetration, market development, product development, and diversification, showing strategic implications and recommended priorities; the page includes a real preview/sample of the analysis so you can judge style and substance before buying. Purchase the full version to receive the complete, ready-to-use company-specific report.
Market Penetration
Cross-sell the subscription suite across current accounts
National Research Corporation can deepen penetration by bundling its four subscription modules—patient experience, employee engagement, market intelligence, and governance—into more seats and sites inside the same health system. This lifts wallet share across existing U.S. and Canada clients without adding a new customer base. In a subscription model, that kind of upsell is usually faster than new-logo sales and can expand recurring revenue per account.
Deepen adoption in integrated health systems
Integrated health systems are already in National Research Corporation’s client base, so the market penetration move is to drive deeper use of patient journey analytics, service recovery, and transitions of care tools across existing accounts. This fits a U.S. provider market with roughly 6,100 hospitals and about 200 integrated delivery networks, where expanding from one module to several can lift stickiness fast. Higher seat and module adoption should improve retention and recurring revenue, since each added workflow raises switching costs.
Expand current use of patient and employee experience analytics
National Research Corporation can deepen market penetration by expanding how often current clients use its patient and employee experience analytics. More touchpoints make the value easier to see, which can lift renewal rates and lower churn in the subscription base. Since the offer already serves both sides of care delivery, wider use inside the same accounts should raise wallet share without adding new markets.
Increase deployment of transparency and brand loyalty tools
NRC can widen use of transparency and reputation tools across current healthcare accounts, helping providers shape consumer choice and protect brand trust. In its latest filing, NRC said software and subscription revenue was a key growth driver, with FY2024 revenue at about $133 million and recurring demand supporting share defense.
- Broader account rollout lifts stickiness
- Transparency tools aid patient choice
- Reputation support strengthens brand position
- Recurring use can defend share
Drive more use of market intelligence and real-time segmentation
NRC’s market intelligence and real-time segmentation can be pushed deeper into current client accounts, so public-perception tracking and community-need scans become part of daily use. That matters in a market where 91% of U.S. adults use the internet, giving NRC a broad base for fast feedback loops and tighter local insight.
- More use inside current accounts
- Sharper read on community needs
- Stronger embedded position
More Seats, Deeper Hospital Penetration
NRC’s market penetration is about selling more modules and seats into the same hospital systems, not chasing new logos. With about 6,100 U.S. hospitals and roughly 200 integrated delivery networks, deeper rollout can raise recurring revenue per account and make churn harder.
| Metric | Use |
|---|---|
| 6,100 | U.S. hospitals |
| 200 | Integrated delivery networks |
| 91% | U.S. adults online |
What is included in the product
Detailed Word Document
Analyzes National Research Corporation’s growth strategy through market penetration, market development, product development, and diversification.
Editable Excel File
Helps National Research Corporation quickly map growth options and reduce strategic uncertainty across existing and new markets.
Reference Sources
Cites authoritative NRC reference sources to validate Ansoff Matrix growth paths, speeding due diligence and making strategy assumptions traceable.
Market Development
Reach more non-profit hospitals and health systems
NRC can grow by selling its existing governance tools to more non-profit hospitals and health systems, without changing the product set. This matters because the U.S. has about 2,000 non-federal non-profit hospitals, giving NRC a large adjacent pool beyond its current accounts. The move lifts revenue by broadening reach, not by adding new offerings.
Expand further into payer organizations
National Research Corporation can expand further into payer organizations by selling its existing analytics and engagement tools to more health plans, with no major product change needed. This is a new-customer move, and the same platform can be used to improve member experience, retention, and service quality across payer accounts. The market is large: the U.S. health insurance sector includes more than 1,000 licensed payers and covers over 300 million people, so even a small win rate can add meaningful recurring revenue.
Grow with more post-acute care providers
Post-acute care providers are already in National Research Corporation’s client base, so the easiest move is to sell the same subscription platform into more facilities and network groups. That is a clean market development play: no new product build, just wider reach across a fragmented care segment with 2025 recurring revenue economics already aligned to expansion.
Extend the suite to more boards and physician leaders
NRC Health can grow by selling its governance tools to more boards and physician leader groups inside the same health system. That is market development: the product stays the same, but the buyer set expands across a U.S. hospital sector with about 6,100 hospitals, so each account can carry more seats and wider use without a new build.
- Same tools, more leadership buyers
- Board, executive, and physician users
- Higher account value, lower product cost
Broaden the Canadian customer footprint
National Research Corporation can widen its Canadian footprint by selling its current patient-experience and analytics tools to more healthcare organizations in a market of about 41 million people. Since it already operates in both the United States and Canada, this is classic market development: more customers, same product set, lower product risk.
- Same solutions, bigger Canadian install base
- Focus on hospitals and health systems
- Use U.S. proof points to speed adoption
National Research Can Grow by Selling the Same Tools to More Buyers
National Research Corporation can pursue market development by selling the same patient-experience and governance tools to more U.S. hospitals, non-profit systems, payers, and Canadian health groups. The U.S. has about 6,100 hospitals and roughly 2,000 non-federal non-profit hospitals, while Canada adds a 41 million-person market. More buyers, same platform, lower product risk.
| Target | Size | Play |
|---|---|---|
| U.S. hospitals | ~6,100 | Expand same tools |
| Non-profit hospitals | ~2,000 | Sell to more systems |
| Canada | 41M people | Grow current footprint |
Full Version Awaits
National Research Corporation Reference Sources
This is the actual Ansoff Matrix analysis document you’ll receive upon purchase—no surprises, just professional quality.
Product Development
Enhance real-time segmentation tools
For National Research Corporation, enhancing real-time segmentation is a product development move: it keeps the same healthcare customer base but adds deeper analytics, more reporting layers, and sharper decision support. NRC already uses live community need, want, and behavior data; adding faster cross-tabs and drill-down views can turn one segment into many actionable views. In FY2025, this kind of upgrade matters because buyers keep paying for tools that cut decision time and improve targeting.
Strengthen health risk assessment capabilities
National Research Corporation can deepen its health risk assessment tools by adding sharper risk flags, longitudinal tracking, and prevention prompts for high-risk patients. That fits product development because it upgrades an existing offer for current healthcare clients, not a new market move. One cited industry benchmark: chronic disease affects 6 in 10 U.S. adults, so better screening and follow-up can drive clear care value.
Improve transition management workflows
National Research Corporation can deepen transition management by adding clearer workflow support, earlier risk alerts, and tighter follow-through for post-discharge care. That matters because CMS can cut Medicare payments by up to 3% for excess readmissions, so better handoffs have direct value. This would strengthen the same provider and payer base without changing the core market.
Expand transparency reporting features
NRC already gives providers transparency tools, so the next step is clearer consumer-facing views: side-by-side comparisons, plain-language labels, and easier cost and quality filters. That fits the U.S. price-transparency push and helps people compare care choices in the same market.
For FY2025, NRC’s latest public filing should be used to tie this upgrade to business impact, but the product logic is simple: better clarity can lift trust, usage, and retention.
- Clearer comparisons
- Better consumer choice
- Stronger market stickiness
Broaden governance dashboards for leaders
For National Research Corporation, broadening governance dashboards can deepen value for the same board, executive, and physician users by adding more oversight metrics, clearer executive reporting, and better enterprise insight. That turns a solid governance tool into a higher-stickiness product, with more decision-ready views and less need for separate reporting work.
Expand leadership reporting depth
Add oversight and risk metrics
Increase product stickiness
Sharper Healthcare Tools That Cut Readmissions and Boost Stickiness
For National Research Corporation, product development means upgrading current healthcare tools with faster segmentation, sharper risk flags, stronger discharge workflow, and clearer consumer comparisons. That can raise stickiness with the same provider, payer, and consumer base. Chronic disease affects 6 in 10 U.S. adults, and CMS can cut Medicare payments by up to 3% for excess readmissions.
| Signal | Data |
|---|---|
| Chronic disease | 6 in 10 adults |
| Readmission penalty | Up to 3% |
Diversification
Build consumer healthcare navigation tools
National Research Corporation can move from provider transparency into consumer navigation by building tools that help patients compare care, costs, and next steps directly.
That is true diversification: a new product line for a new market, not just a deeper sell to health systems.
With U.S. health spending near $5 trillion and consumers facing higher out-of-pocket costs, clear navigation tools can make NRC more relevant beyond hospital clients.
Create employer wellness analytics
National Research Corporation can diversify by turning its employee engagement and health risk assessment tools into an employer wellness analytics offer. That reaches a new buyer group beyond healthcare providers, while keeping the same core data strengths. With about 156 million Americans covered by employer-sponsored plans in 2025, the addressable market is large and adjacent.
Develop community health screening services
NRC Health can use its segmentation and risk-scoring tools to launch community health screening services for schools, employers, and local nonprofits, reaching new end users beyond hospitals. This is a true diversification move: a new market with a new service model. U.S. nonprofit community health centers already serve more than 30 million people, showing the scale of demand.
Launch broader healthcare reputation intelligence services
National Research Corporation can extend its existing work in brand awareness, public perception, and competitive positioning into a broader healthcare reputation-intelligence package for non-client systems and adjacent providers. The U.S. healthcare industry spent about 18.3% of GDP in 2024, so even small share gains in trust and patient choice can matter.
This diversification moves National Research Corporation from account analytics to a new market application: packaged reputation monitoring, benchmarking, and alerting sold as a standalone service.
- New market: beyond current provider accounts
- New offer: packaged reputation intelligence
- Value: deeper insight, wider buyer base
Enter preventative care support for new buyer groups
NRC can move preventative care support into payer, employer, and provider buyers beyond its core account base, using the same risk-stratification and wellness analytics already in place. That is classic diversification: a new market, with a familiar data engine. In FY2025, NRC Health still leaned on recurring analytics-led demand, which makes this adjacency lower friction than a blank-slate launch.
- New buyers, same analytics base
- Uses risk and wellness tools
- Expands beyond core accounts
New Buyers, Same Data Engine
National Research Corporation’s diversification move is to sell its analytics into new buyers, not just more services to current health-system clients. That fits Ansoff because it is a new market with a new offer.
In FY2025, the biggest nearby pools are employer plans for about 156 million people and U.S. health spending near $5 trillion, so navigation, wellness, and reputation tools have real scale.
Table: new buyer groups, same data engine, wider revenue base.
| Move | FY2025 signal |
|---|---|
| Employer wellness | 156 million covered |
| Consumer navigation | $5 trillion spend |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.